These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 23076129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.
    Kumar JS, Parsey RV, Kassir SA, Majo VJ, Milak MS, Prabhakaran J, Simpson NR, Underwood MD, Mann JJ, Arango V.
    Brain Res; 2013 Apr 24; 1507():11-8. PubMed ID: 23454434
    [Abstract] [Full Text] [Related]

  • 3. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L, Verdurand M, Vacher B, Blanc E, Le Bars D, Newman-Tancredi A, Zimmer L.
    Eur J Nucl Med Mol Imaging; 2010 Mar 24; 37(3):594-605. PubMed ID: 19789870
    [Abstract] [Full Text] [Related]

  • 4. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
    Yokoyama C, Mawatari A, Kawasaki A, Takeda C, Onoe K, Doi H, Newman-Tancredi A, Zimmer L, Onoe H.
    Int J Neuropsychopharmacol; 2016 Dec 24; 19(12):. PubMed ID: 27608810
    [Abstract] [Full Text] [Related]

  • 5. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L, Becker G, Vacher B, Billard T, Lancelot S, Newman-Tancredi A, Zimmer L.
    J Nucl Med; 2012 Jun 24; 53(6):969-76. PubMed ID: 22577236
    [Abstract] [Full Text] [Related]

  • 6. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.
    Milak MS, Severance AJ, Ogden RT, Prabhakaran J, Kumar JS, Majo VJ, Mann JJ, Parsey RV.
    J Nucl Med; 2008 Apr 24; 49(4):587-96. PubMed ID: 18344443
    [Abstract] [Full Text] [Related]

  • 7. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.
    Vidal B, Sebti J, Verdurand M, Fieux S, Billard T, Streichenberger N, Troakes C, Newman-Tancredi A, Zimmer L.
    Neuropharmacology; 2016 Oct 24; 109():88-95. PubMed ID: 27183968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.
    Stenkrona P, Halldin C, Lundberg J.
    Eur Neuropsychopharmacol; 2013 Oct 24; 23(10):1190-8. PubMed ID: 23428337
    [Abstract] [Full Text] [Related]

  • 10. In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue.
    Hendry N, Christie I, Rabiner EA, Laruelle M, Watson J.
    Nucl Med Biol; 2011 Feb 24; 38(2):273-7. PubMed ID: 21315283
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.
    Majo VJ, Milak MS, Prabhakaran J, Mali P, Savenkova L, Simpson NR, Mann JJ, Parsey RV, Kumar JS.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5598-604. PubMed ID: 23816046
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.
    Kumar JS, Majo VJ, Hsiung SC, Millak MS, Liu KP, Tamir H, Prabhakaran J, Simpson NR, Van Heertum RL, Mann JJ, Parsey RV.
    J Med Chem; 2006 Jan 12; 49(1):125-34. PubMed ID: 16392798
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.
    Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV.
    Biol Psychiatry; 2009 Aug 01; 66(3):223-30. PubMed ID: 19278673
    [Abstract] [Full Text] [Related]

  • 19. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
    Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L.
    Eur J Med Chem; 2010 Sep 01; 45(9):3740-51. PubMed ID: 20605276
    [Abstract] [Full Text] [Related]

  • 20. In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.
    Milak MS, Severance AJ, Prabhakaran J, Kumar JS, Majo VJ, Ogden RT, Mann JJ, Parsey RV.
    J Cereb Blood Flow Metab; 2011 Jan 01; 31(1):243-9. PubMed ID: 20571518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.